In Vivo is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Sarnoff Corp.

Division of SRI International
www.sarnoff.com

Latest From Sarnoff Corp.

Recent Financings of Private Companies (02/2010)

Start-Up's monthly comprehensive review of emerging life science companies that have received venture funding during the month, including companies in the pharmaceutical, medical device, diagnostic and research instrumentation and reagent sectors.

Devices for a Diabetes Epidemic

With an increasing emphasis on tight glycemic control in diabetes care, innovative devices could play a big role, but diabetes is a deceptively complex market. Innovative companies need to differentiate themselves, yet not venture too far outside existing industry dynamics. As the first real-time continuous glucose monitors come to market, a handful of start-ups hopes to be ready for the second generation. Many of these are taking a side excursion into the market for in-hospital glucose monitoring, once a sleepy market but now growing rapidly as outcomes data shows reduced mortality and morbidty in intensively managed hyperglycemic hospital patients.
Medical Device

A Convergence Problem: Getting the Drug on the Device

Drug-eluting stents are highly successful medical devices but even their manufacturers don't have adequate solutions for a hidden problem in drug-device combinations; the best way to get the drug on the device. Sarnoff Corp.has a new technology for addressing this complex process. Called electro-static deposition, it brings increased flexibility, reproducibility, accuracy, and uniformity to a manufacturing process which using current methods is costly and inefficient,
Medical Device Manufacturing

Hearing Aids: Innovators Must Change the Channel

Ten percentage of the population in industrialized companies could benefit from hearing aids, and since the market remains 80% unpenetrated, new hearing aid companies and their financial backers see an enormous opportunity. But the hearing industry presents unique challenges compared to other medical device markets; the poor performance of past devices keeps people from buying hearing aids, as does the lack of reimbursement. Profitability is difficult for manufacturers to achieve, because manufacturing of the custom devices doesn't benefit from economies of scale. Finally, small companies have a tough time getting past the gatekeepers of the hearing industry--audiologists who have entrenched relationships with dominant manufacturers. New companies are entering the market with widely different approaches, some based on technology, some based on changing distribution channels. For some, the new approaches have clearly failed; others are embarking on new strategies that have yet to play out.
Medical Device Leadership
See All

Company Information

  • Industry
  • Diversified
  • Therapeutic Areas
  • Alias(es)
  • Ownership
  • Headquarters
  • Worldwide
    • North America
      • USA
  • Parent & Subsidiaries
  • SRI International
  • Senior Management
  • David J Warnock, CFO
    James Carnes, PhD, Pres.
    Curtis R Carlson, PhD, EVP, Ventures & Licensing
  • Contact Info
  • Sarnoff Corp.
    Phone: (609) 734-2000
    201 Washington Rd.
    Princeton, NJ 08543-5300
    USA
Advertisement
Advertisement
UsernamePublicRestriction

Register